Selective Minimally Invasive Treatment of Solid Tumors

CAPS Medical is a medical device company focused on development and commercialization of a minimally invasive and selective cancer treatment using (NTAP) Non-Thermal Atmospheric Plasma, applicable for a wide range of solid tumors.

CAPS Medical’s Benefits:

Deliver minimally invasive selective cancer treatment

Enable fine tuning of the delivered energy dose

Our Story

CAPS Medical was founded following extensive scientific research as a collaboration between the Technion’s Plasma Lab and Rambam Medical Center’s Cancer Lab, united in the fight against cancer. The company is addressing an unmet need in the multi billion dollar oncology therapeutics market.

Supported by a panel of key scientific and clinical leaders

New Webpage Coming Soon!

Contact us

For more information please contact